William Blair analyst Brandon Vazquez has maintained their bullish stance on TCMD stock, giving a Buy rating today.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Brandon Vazquez has given his Buy rating due to a combination of factors that highlight Tactile Systems Technology’s promising growth trajectory. The company’s recent financial performance exceeded expectations, with sales and adjusted EBITDA surpassing estimates by $6 million, driven by strong results in core lymphedema and a significant increase in AffloVest sales. This positive momentum, coupled with a robust balance sheet, enhances confidence in the new management team’s ability to sustain improved outcomes.
Key initiatives contributing to this growth include an expanded salesforce, enhanced CRM systems, and innovative pilot programs focused on patient engagement and AI-driven sales productivity. Additionally, recent updates in CMS coverage have provided clearer pathways for FlexiTouch access, further supporting growth prospects. As these efforts continue to mature and new products like the next-generation AffloVest gain traction, the company is well-positioned for sustained growth into 2026. With the stock trading at a favorable valuation relative to projected sales, Vazquez believes there is significant upside potential, justifying the Buy rating.
According to TipRanks, Vazquez is an analyst with an average return of -0.8% and a 42.47% success rate. Vazquez covers the Healthcare sector, focusing on stocks such as Ceribell, Inc., Intuitive Surgical, and Edwards Lifesciences.
In another report released today, BTIG also upgraded the stock to a Buy with a $28.00 price target.